Learn about the global patient blood management market through The Business Research Company, which provides information on patient blood management market size, patient blood management market drivers and restraints, patient blood management market players, the COVID-19 impact on the patient blood management market, and more.

The global patient blood management market size is expected to grow from $11.83 billion in 2021 to $12.82 billion in 2022 at a compound annual growth rate (CAGR) of 8.4%. The global patient blood management market is then expected to grow to $15.94 billion in 2026 at a CAGR of 5.6%.

The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market.

Request A Sample For The Global Patient Blood Management Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3240&type=smp

The market for patient blood management consists of sales of instruments, accessories, software, reagents, and kits used in the management of blood and blood products of patients. Patient blood management is a patient-focused, evidence-based and systematic approach to optimize care of patients, who might need a blood transfusion, by optimizing patients’ blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions.

Global Patient Blood Management Market Segments Include:

By Product: Instruments, Accessories, Reagents and Kits, Software

By Component: Plasma, Whole Blood, Red Blood Cells

By Application: Hospital, Clinic, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss. Clinicians can economically collect sterile, anticoagulated blood without any need for specialized resources. By this, the upfront shed blood collection cost decreases, allogenic transfusions can be avoided with improved outcomes such as decreased patient mortality, low incidence of infections, and reduced risk of multi-organ failure.

TBRC’s patient blood management market report covers:

Major Market Players: Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, Kaneka Corporation, and Bio-Rad Laboratories Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-2021) and ten years forecast (2022-2026-2031)

The Patient Blood Management Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides patient blood management market overviews, analyzes and forecasts market size, share, patient blood management market players, patient blood management market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s patient blood management market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Blood Transfusion Diagnostics Global Market Report 2022

Remote Patient Monitoring Devices And Equipment Global Market Report 2022

Patient Monitoring Devices Global Market Report 2022

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: